+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Susceptibility of equine chorionic girdle cells to lymphokine-activated killer cell activity



Susceptibility of equine chorionic girdle cells to lymphokine-activated killer cell activity



American Journal of Reproductive Immunology 36(3): 184-190



PROBLEM: Equine chorionic girdle cells are a subpopulation of highly invasive trophoblast cells that attach and invade the uterine epithelium on Day 35 (Day 0 = day of ovulation). These invading chorionic girdle cells form endometrial cups that are associated with a marked local maternal leukocytic response that may result in the demise of the cups at Day 120 of pregnancy. Once endometrial cups become established in the uterine wall they do not express MHC antigens, and therefore may only be susceptible to non-MHC restricted cytotoxic cells. The susceptibility of cultured chorionic girdle cells to LAK cell cytotoxicity was tested in order to evaluate the role of this type of cytotoxicity in the life-cycle of endometrial cup tissue. METHODS: Chorionic girdle cells from ten Day 34 conceptuses were collected, cultured, and used as a target cell in a lymphokine activated killer assay to determine if these cells were susceptible to lymphokine activated killing. RESULTS: Cultured chorionic girdle cells demonstrated similar in vitro morphological features and patterns of antigen expression to those seen in vivo in endometrial cups. Cultured chorionic girdle cells were susceptible to lymphokine activated killing. CONCLUSIONS: Lymphokine activated killer cells may play a role in the degeneration of endometrial cup tissue. The potential mechanisms of regulation of uterine LAK cell activity in the horse are discussed.

(PDF emailed within 0-6 h: $19.90)

Accession: 002973316

Download citation: RISBibTeXText

PMID: 8874715

DOI: 10.1111/j.1600-0897.1996.tb00160.x


Related references

The anti tumor efficacy of lymphokine activated killer cells and recombinant interleukin 2 in vivo direct correlation between reduction of established metastases and cytolytic activity of lymphokine activated killer cells. Journal of Immunology 136(10): 3899-3909, 1986

Lymphokine activated killer cell phenomenon 4. lysis by lymphokine activated killer cell clones of fresh human tumor cells from autologous and multiple allogeneic tumors. Journal of the National Cancer Institute 75(1): 67-76, 1985

Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells. Journal of Experimental Medicine 158(4): 1356-1361, 1983

Lymphokine-activated killer traffic assay and our preliminary clinical results of regional arterial infusion of lymphokine-activated killer cells for renal cell carcinoma. Urologia Internationalis 47 Suppl 1: 127-131, 1991

Natural killer cell activity, activity of lymphokine-activated killer cells (LAK activity), and killer-helper factors (KHF). Nihon Rinsho. Japanese Journal of Clinical Medicine 63 Suppl 7: 781-783, 2005

Natural killer cell activity, activity of lymphokine activated killer cells (LAK activity), killer helper factor (KHF). Nihon Rinsho. Japanese Journal of Clinical Medicine 57 Suppl: 666-669, 2000

Mechanism of interferon gamma-induced protection of human gliosarcoma cells from lymphokine-activated killer lysis: division of lymphokine-activated killer cells into natural killer- and T-like cells. Neurosurgery 31(3): 534-540, 1992

Lymphokine activated killer lak cell activity in b and t chronic lymphoid leukemia defective lak generation and reduced susceptibility of the leukemic cells to allogeneic and autologous lak effectors. Blood 76(7): 1349-1354, 1990

Differential susceptibility of tumor cells to the antitumor cytotoxic effect of alpha cd3 induced activated killer cd3 ak cells and lymphokine activated killer lak cells. Proceedings of the American Association for Cancer Research Annual Meeting 30: 367, 1989

Lymphokine activated killer cells from umbilical cord blood show higher antitumor effect against anaplastic astrocytoma cell line (U87) and medulloblastoma cell line (TE671) than lymphokine activated killer cells from peripheral blood. Child's Nervous System 20(3): 154-162, 2004

Role of CD9 in B cell susceptibility to lysis by lymphokine activated killer cells. Journal of Cellular Biochemistry Supplement 0(17 PART B): 189, 1993

Low susceptibility of choriocarcinoma cell lines to lymphokine activated killer cells. Acta Obstetrica et Gynaecologica Japonica (Japanese Edition) 38(11): 2091-2092, 1986

Low susceptibility of choriocarcinoma cell lines to lymphokine activated killer (LAK) cells. Nihon Sanka Fujinka Gakkai Zasshi 41(1): 1-6, 1989

Low susceptibility of choriocarcinoma cell lines to lymphokine-activated killer (LAK) cells. Nihon Sanka Fujinka Gakkai Zasshi 38(11): 2091-2092, 1986

Natural killer and lymphokine activated killer cells activity after t cell depletion. Experimental Hematology 16(6): 517, 1988